Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pierre Regent Leblanc, Ph.D.

Concepts (172)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Pierre Leblanc's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Pierre Leblanc has written about over time.
Drug Approval, 1 publications between 2012 and 2012, average publication date June 2012. Vaccines, 1 publications between 2012 and 2012, average publication date June 2012. Communicable Diseases, Emerging, 2 publications between 2012 and 2014, average publication date March 2013. Avidin, 1 publications between 2014 and 2014, average publication date January 2014. Lassa Fever, 1 publications between 2014 and 2014, average publication date January 2014. Viral Vaccines, 1 publications between 2014 and 2014, average publication date January 2014. Drug Discovery, 2 publications between 2012 and 2016, average publication date May 2014. Bacterial Proteins, 2 publications between 2014 and 2014, average publication date June 2014. Antibodies, 1 publications between 2015 and 2015, average publication date August 2015. Nuclear Receptor Subfamily 4, Group A, Member 1, 1 publications between 2015 and 2015, average publication date August 2015. HSP70 Heat-Shock Proteins, 3 publications between 2014 and 2018, average publication date September 2015. Nuclear Receptor Subfamily 4, Group A, Member 2, 3 publications between 2014 and 2019, average publication date September 2016. Parkinson Disease, 5 publications between 2016 and 2023, average publication date February 2020. Pluripotent Stem Cells, 2 publications between 2018 and 2022, average publication date March 2020. Dopamine, 4 publications between 2020 and 2023, average publication date January 2022. Aphakia, 1 publications between 2022 and 2022, average publication date May 2022. Tyrosine 3-Monooxygenase, 1 publications between 2023 and 2023, average publication date July 2023.

To see the data from this visualization as text, click here.
Leblanc's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (172)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.